Brought to you by 
Sunesis completes $39.06mm IPO
27 Apr 2021
Executive Summary
Sunesis Pharmaceuticals (therapeutics for cancer and inflammatory diseases) has netted $39.06mm with the initial public offering of 6mm common shares priced at $7 each. The company had originally hoped to bring in up to $86.25mm when it first filed in December 2004.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Sunesis completes $39.06mm IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice